Methylation as a biomarker for head and neck cancer

Oral Oncology

Volumn 50, Issue 6, 2014, Pages 587-592

  Arantes, L M R B ^a,b   De Carvalho, A C ^b   Melendez, M E ^b   Carvalho, A L ^b   Goloni Bertollo, E M ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

Biomarkers; DNA methylation; Exfoliated cells; Head and neck cancer; Plasma; Saliva; Serum

Indexed keywords

BIOLOGICAL MARKER; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; METHYL GROUP; TUMOR MARKER;

ANEUPLOIDY; CANCER CELL; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CHROMATIN STRUCTURE; DNA METHYLATION; EPIGENETICS; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE INSERTION; GENOME IMPRINTING; HEAD AND NECK CANCER; HEALTH CARE COST; HETEROZYGOSITY LOSS; HIGH RISK POPULATION; HISTONE MODIFICATION; HUMAN; LARYNX CANCER; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; PHARYNX CANCER; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; QUALITY OF LIFE; REVIEW; SALIVA ANALYSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; GENETIC EPIGENESIS; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; HEAD AND NECK NEOPLASMS; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84900517027     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.02.015     Document Type: Review

References (84)

1. GLOBOCAN. International Agency for Research on Cancer - World Health Organization (WHO); 2012.
2. S.S. Napier, and P.M. Speight Natural history of potentially malignant oral lesions and conditions: an overview of the literature J Oral Pathol Med 37 2008 1 10
3. V. Boonkitticharoen et al. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma Arch Otolaryngol Head Neck Surg 134 2008 1305 1311
4. A. Eleftheriadou et al. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine Anticancer Res 26 2006 2345 2348
5. A.K. Lo et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells Neoplasia 8 2006 173 180
6. P.T. Hennessey, W.H. Westra, and J.A. Califano Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications J Dent Res 88 2009 300 306
7. S. Marur, and A.A. Forastiere Head and neck cancer: changing epidemiology, diagnosis, and treatment Mayo Clin Proc 83 2008 489 501
8. A.L. Carvalho et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma Clin Cancer Res 14 2008 97 107
9. D. Kwong, J. Sham, and D. Choy The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients Int J Radiat Oncol Biol Phys 30 1994 1029 1036
10. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
11. S. Nagata et al. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma Cancer 118 2012 4298 4308
12. A.P. Feinberg Cancer epigenetics takes center stage Proc Natl Acad Sci USA 98 2001 392 394
13. W.Y. Tang, and S.M. Ho Epigenetic reprogramming and imprinting in origins of disease Rev Endocr Metab Disord 8 2007 173 182
14. R.A. Stein Epigenetics - the link between infectious diseases and cancer JAMA 305 2011 1484 1485
15. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 1057 1068
16. M. Rodriguez-Paredes, and M. Esteller Cancer epigenetics reaches mainstream oncology Nat Med 17 2011 330 339
17. M. Esteller Epigenetic changes in cancer F1000 Biol Rep 3 2011 9
18. J.S. Graham, S.B. Kaye, and R. Brown The promises and pitfalls of epigenetic therapies in solid tumours Eur J Cancer 45 2009 1129 1136
19. J. Tost DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker Mol Biotechnol 44 2010 71 81
20. D. Rodenhiser, and M. Mann Epigenetics and human disease: translating basic biology into clinical applications CMAJ 174 2006 341 348
21. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
22. C. Sweeney et al. Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors Genes Chromosomes Cancer 48 2009 1 9
23. J.M. Teodoridis, G. Strathdee, and R. Brown Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker Drug Resist Updat 7 2004 267 278
24. G.M. Poage et al. Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted PLoS One 5 2010 e9651
25. S. Lee, W.H. Kim, H.Y. Jung, M.H. Yang, and G.H. Kang Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma Am J Pathol 161 2002 1015 1022
26. S.B. Baylin et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer Hum Mol Genet 10 2001 687 692
27. M. Esteller Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes Eur J Cancer 36 2000 2294 2300
28. M. Esteller, P.G. Corn, S.B. Baylin, and J.G. Herman A gene hypermethylation profile of human cancer Cancer Res 61 2001 3225 3229
29. M.O. Hoque et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer J Clin Oncol 24 2006 4262 4269
30. M. van Rijnsoever, F. Grieu, H. Elsaleh, D. Joseph, and B. Iacopetta Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands Gut 51 2002 797 802
31. J.A. Tsou, J.A. Hagen, C.L. Carpenter, and I.A. Laird-Offringa DNA methylation analysis: a powerful new tool for lung cancer diagnosis Oncogene 21 2002 5450 5461
32. M. Hasegawa et al. Patterns of gene promoter methylation in squamous cell cancer of the head and neck Oncogene 21 2002 4231 4236
33. R.P. Dikshit et al. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers Cancer 110 2007 1745 1751
34. M. Loyo et al. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma Int J Cancer 128 2011 1393 1403
35. S.L. Rosas et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients Cancer Res 61 2001 939 942
36. S. Shintani, Y. Nakahara, M. Mihara, Y. Ueyama, and T. Matsumura Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas Oral Oncol 37 2001 498 504
37. M. Viswanathan, N. Tsuchida, and G. Shanmugam Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma Int J Cancer 105 2003 41 46
38. K. Wang, T. Ling, H. Wu, and J. Zhang Screening of candidate tumor-suppressor genes in 3p21.3 and investigation of the methylation of gene promoters in oral squamous cell carcinoma Oncol Rep 29 2013 1175 1182
39. S. Hwang et al. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas Cancer 2013
40. J. Schussel et al. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions Clin Cancer Res 19 2013 3268 3275
41. H. De Schutter, H. Geeraerts, E. Verbeken, and S. Nuyts Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only Oncol Rep 21 2009 507 513
42. K. Steinmann, A. Sandner, U. Schagdarsurengin, and R.H. Dammann Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma Oncol Rep 22 2009 1519 1526
43. M. Sanchez-Cespedes et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res 60 2000 892 895
44. K. Ogi et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma Clin Cancer Res 8 2002 3164 3171
45. Y. Misawa et al. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer Cancer 2013
46. K. Misawa et al. Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer Transl Oncol 6 2013 338 346
47. E. Ishida et al. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma Oral Oncol 41 2005 614 622
48. D. Weiss, C. Stockmann, K. Schrodter, and C. Rudack Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma Cell Oncol (Dordr) 36 2013 213 224
49. S. Pierini et al. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients Head Neck 2013
50. K. Hibi et al. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma Clin Cancer Res 7 2001 3135 3138
51. W.A. Palmisano et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res 60 2000 5954 5958
52. D. Sidransky Emerging molecular markers of cancer Nat Rev Cancer 2 2002 210 219
53. T.S. Wong et al. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma Clin Cancer Res 10 2004 2401 2406
54. C.A. Righini et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence Clin Cancer Res 13 2007 1179 1185
55. A.L. Carvalho et al. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance Clin Cancer Res 17 2011 4782 4789
56. M.M. Rettori et al. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients Carcinogenesis 34 2013 20 27
57. A.L. Longo et al. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma Head Neck 2013
58. G. Supic, R. Kozomara, N. Jovic, K. Zeljic, and Z. Magic Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas Oral Oncol 47 2011 702 708
59. H.K. Tan et al. Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas Br J Cancer 99 2008 357 363
60. S. Demokan et al. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer Head Neck 34 2012 1470 1475
61. K. Chen et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma Arch Otolaryngol Head Neck Surg 133 2007 1131 1138
62. C.S. Nayak et al. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma Laryngoscope 117 2007 1376 1380
63. G.M. Poage et al. Identification of an epigenetic profile classifier that is associated with survival in head and neck cancer Cancer Res 72 2012 2728 2737
64. M.M. Rettori et al. TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors J Transl Med 11 2013 316
65. R.V. de Moraes et al. E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer Head Neck 30 2008 85 92
66. C.J. Marsit, M.R. Posner, M.D. McClean, and K.T. Kelsey Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma Cancer 113 2008 1566 1571
67. L. Ai et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases Mod Pathol 16 2003 944 950
68. J.L. Roh et al. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study Clin Cancer Res 19 2013 2528 2540
69. P. Sinha et al. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue Head Neck 31 2009 1423 1430
70. T.S. Wong et al. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR Eur J Cancer 39 2003 1881 1887
71. K.M. Pattani et al. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy Cancer Prev Res (Philadelphia) 3 2010 1093 1103
72. L.M. Lima et al. DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors Histopathology 60 2012 489 496
73. J.K. Stephen et al. DNA hypermethylation markers of poor outcome in laryngeal cancer Clin Epigenetics 1 2010 61 69
74. A. Ghosh et al. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck Ann Surg Oncol 19 Suppl 3 2012 S528 538
75. D. Yin, and M. Dong [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma] Lin Chuang Er Bi Yan Hou Ke Za Zhi 258 19 2005 253 255
76. K. Misawa et al. Epigenetic inactivation of galanin receptor 1 in head and neck cancer Clin Cancer Res 14 2008 7604 7613
77. D. Li et al. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma Am J Pathol 182 2013 64 70
78. S. Demokan et al. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses Int J Cancer 127 2010 2351 2359
79. S. Ekizoglu et al. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer Transl Res 162 2013 122 129
80. C. Zuo et al. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 13 2004 967 975
81. J. Olasz et al. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age Oncol Rep 18 2007 105 112
82. G. Supic, R. Kozomara, N. Jovic, K. Zeljic, and Z. Magic Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers Oral Dis 17 2011 794 800
83. Q. He et al. Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma Oncol Lett 2 2011 725 729
84. W. Sun et al. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer Clin Cancer Res 18 2012 1082 1091